COLESTID

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

COLESTIPOL HYDROCHLORIDE

Dostopno od:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

Koda artikla:

B04AD

Farmacevtska oblika:

GRANULES

Sestava:

COLESTIPOL HYDROCHLORIDE 5 G/SACHET

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

FARMEA, FRANCE

Terapevtske indikacije:

Adjunctive therapy to diet in the managnent of elevated cholesterol levels.

Datum dovoljenje:

2014-08-31

Navodilo za uporabo

ةرارملا يف ىصح ،ةرارملا سيك باهتلا
�امد أيقتت امبر وأ ادج انكاد زاربلا
ةحبذ) ردصلا يف طغض وأ جاعزنا ،ردصلا يف
ملاآ �ةرفصلا ىلإ لئام دلج وأ
يف قيض
�(tachycardia) عيرس ضبن ،(angina pectoris ،ةيردص
تايوتسم �دلجلا باهتلا ،ىرش وأ دلجلا
يف ةكح �سفنتلا يف تابوعص وأ سفنتلا
ىوتسم عافترا ،نينلالأا نيمأ ةلقان
عافترا) دبكلا تاميزنلإ ةميلس ريغ وأ
ةعفترم
ةنيعم ةدام) مدلا يف
ّ
يولقلا زاتفسوفلا ىوتسم عافترا
�(تاتراپسلأا
نيمأ ةلقان
�(ةيطيحم ةمذو) نيديلا عباصأ وأ نيمدقلا
يتحار ،نيلحاكلا مروت ،(مدلا يف
.فعضلاب روعش
ضعب يفو تاينهدلا كمسج اهيف صتمي يتلا
ةقيرطلا يف
™
ديتسيلوك رثؤي
ل
ّ
مكم لوانتب بيبطلا ىصوي دق .( K و A ,D ,E )
نهدلا يف ةبئاذلا تانيماتيفلا
.ثدحت دق ةلاحلا هذه نأ دقتعي ناك اذإ
تانيماتيفلا نم
ةتقؤم نوكت ةلاحلا هذه .مدلا يف
تانيماتيفلاو تاينهدلا ىوتسم عفتري نأ
ل
َ
متح
ُ
ي
.ابلاغ
نم تيناع اذإ وأ ةيبناجلا ضارعلأا نم يأ
مقافت اذإ ،يبناج ضراع رهظ اذإ
.بيبطلا ةراشتسا كيلع ،ةرشنلا يف ركذ
ُ
ي مل يبناج ضراع
طبار ىلع طغضلا
ربع ةيبناجلا
ضارعلأاب ة
ّ
حصلا
ةرازو غلابإ
نكمي
ةحفصلا يف دوجوملا ،"يئاودلا جلاعلا
ببسب ةيبناجلا ضارعلأا نع غلابلإا"
ىلإ كهجوي يذلا ،( www.health.gov.il ) ة
ّ
حصلا ةرازو عقومل ةيسيئرلا
ىلإ لوخدلا ربع وأ ،ةيبناجلا ضارعلأا نع
غلابلإل تنرتنلإا

Lastnosti izdelka

Colestid LPD CC 281120
Page 1 of 5
2013-0002201
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Colestid
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each sachet contains 5 g of colestipol hydrochloride.
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Granules for oral suspension.
Yellow to orange colored free-flowing beads
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Colestid is indicated as adjunctive therapy to diet in the management
of elevated cholesterol
levels.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Treatment for elevated serum cholesterol levels should begin with
dietary therapy. A
minimum of six months of dietary therapy and counseling should usually
be undertaken before
initiating drug therapy; shorter periods can be considered in patients
with severe elevations of
LDL-cholesterol (>225 mg/dl or 5.8 mmol/L) or definite Coronary Heart
Disease. Drug
therapy should be added to dietary therapy, and not substituted for
it.
Colestipol hydrochloride granules should never be taken in dry form.
Esophageal spasm or
respiratory distress can result from attempting to swallow the
granules dry.
Route of administration: Oral, mixed with water or other fluids.
Adults:
The recommended initial daily adult dosage of colestipol hydrochloride
is 5 grams either once
or twice daily.
For adults colestipol hydrochloride is recommended in doses of 5 - 30
grams taken as one dose
or two divided doses. Initiation of therapy is recommended at 5 grams
either once or twice
daily with 5 gram increments at one month intervals. Appropriate use
of lipid profiles
including LDL-cholesterol and triglycerides is advised so that
optimal, but not excessive doses
are used to obtain the desired therapeutic effect on LDL-cholesterol
level. If the desired
therapeutic effect is not obtained at a dose of 5 - 30 grams/day with
good compliance and
acceptable side-effects, combined therapy or alternate treatment
should be considered.
Patients should take other drugs at least one hour before or four